Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study

<i>Background and Objectives: </i>Pain is one of the most common symptoms that weighs on life’s quality and health expenditure. In a reality where increasingly personalized therapies are needed, the early use of genetic tests that highlights the individual response to analgesic drugs cou...

Full description

Bibliographic Details
Main Authors: Lorenzo Panella, Laura Volontè, Nicola Poloni, Antonello Caserta, Marta Ielmini, Ivano Caselli, Giulia Lucca, Camilla Callegari
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1010-660X/55/5/147
_version_ 1797721737729671168
author Lorenzo Panella
Laura Volontè
Nicola Poloni
Antonello Caserta
Marta Ielmini
Ivano Caselli
Giulia Lucca
Camilla Callegari
author_facet Lorenzo Panella
Laura Volontè
Nicola Poloni
Antonello Caserta
Marta Ielmini
Ivano Caselli
Giulia Lucca
Camilla Callegari
author_sort Lorenzo Panella
collection DOAJ
description <i>Background and Objectives: </i>Pain is one of the most common symptoms that weighs on life’s quality and health expenditure. In a reality where increasingly personalized therapies are needed, the early use of genetic tests that highlights the individual response to analgesic drugs could be a valuable help in clinical practice. The aim of this preliminary study is to observe if the therapy set to 5 patients suffering of chronic or acute pain is concordant to the Pharmacogenetic test (PGT) results. <i>Materials and Methods: </i>This preliminary study compares the genetic results of pharmacological effectiveness and tolerability analyzed by the genetic test Neurofarmagen Analgesia, with the results obtained in clinical practice of 5 patients suffering from acute and chronic pain. <i>Results:</i> Regarding the genetic results of the 5 samples analyzed, 2 reports were found to be completely comparable with the evidences of the clinical practice, while in 3 reports the profile of tolerability and effectiveness were partially discordant. <i>Conclusion: </i>In light of the data not completely overlapping with results observed in clinical practice, further studies would be appropriate in order to acquire more information on the use of Neurofarmagen<i> </i>in routine clinical settings.
first_indexed 2024-03-12T09:37:39Z
format Article
id doaj.art-e57f6291181c4faba897e87c72e55777
institution Directory Open Access Journal
issn 1010-660X
language English
last_indexed 2024-03-12T09:37:39Z
publishDate 2019-05-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-e57f6291181c4faba897e87c72e557772023-09-02T13:32:09ZengMDPI AGMedicina1010-660X2019-05-0155514710.3390/medicina55050147medicina55050147Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary StudyLorenzo Panella0Laura Volontè1Nicola Poloni2Antonello Caserta3Marta Ielmini4Ivano Caselli5Giulia Lucca6Camilla Callegari7Department of Rehabilitation, ASST Gaetano Pini—CTO, Via Isocrate 19, 20122 Milan, ItalyDepartment of Rehabilitation, ASST Gaetano Pini—CTO, Via Isocrate 19, 20122 Milan, ItalyDepartment of Medicine and Surgery, Division of Psychiatry, University of Insubria, Viale Luigi Borri 57, 21100 Varese, ItalyDepartment of Rehabilitation, ASST Gaetano Pini—CTO, Via Isocrate 19, 20122 Milan, ItalyDepartment of Medicine and Surgery, Division of Psychiatry, University of Insubria, Viale Luigi Borri 57, 21100 Varese, ItalyDepartment of Medicine and Surgery, Division of Psychiatry, University of Insubria, Viale Luigi Borri 57, 21100 Varese, ItalyDepartment of Medicine and Surgery, Division of Psychiatry, University of Insubria, Viale Luigi Borri 57, 21100 Varese, ItalyDepartment of Medicine and Surgery, Division of Psychiatry, University of Insubria, Viale Luigi Borri 57, 21100 Varese, Italy<i>Background and Objectives: </i>Pain is one of the most common symptoms that weighs on life’s quality and health expenditure. In a reality where increasingly personalized therapies are needed, the early use of genetic tests that highlights the individual response to analgesic drugs could be a valuable help in clinical practice. The aim of this preliminary study is to observe if the therapy set to 5 patients suffering of chronic or acute pain is concordant to the Pharmacogenetic test (PGT) results. <i>Materials and Methods: </i>This preliminary study compares the genetic results of pharmacological effectiveness and tolerability analyzed by the genetic test Neurofarmagen Analgesia, with the results obtained in clinical practice of 5 patients suffering from acute and chronic pain. <i>Results:</i> Regarding the genetic results of the 5 samples analyzed, 2 reports were found to be completely comparable with the evidences of the clinical practice, while in 3 reports the profile of tolerability and effectiveness were partially discordant. <i>Conclusion: </i>In light of the data not completely overlapping with results observed in clinical practice, further studies would be appropriate in order to acquire more information on the use of Neurofarmagen<i> </i>in routine clinical settings.https://www.mdpi.com/1010-660X/55/5/147painanalgesicpharmacogenetic testingpharmacological therapyeffectivenessadverse effects
spellingShingle Lorenzo Panella
Laura Volontè
Nicola Poloni
Antonello Caserta
Marta Ielmini
Ivano Caselli
Giulia Lucca
Camilla Callegari
Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study
Medicina
pain
analgesic
pharmacogenetic testing
pharmacological therapy
effectiveness
adverse effects
title Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study
title_full Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study
title_fullStr Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study
title_full_unstemmed Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study
title_short Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study
title_sort pharmacogenetic testing in acute and chronic pain a preliminary study
topic pain
analgesic
pharmacogenetic testing
pharmacological therapy
effectiveness
adverse effects
url https://www.mdpi.com/1010-660X/55/5/147
work_keys_str_mv AT lorenzopanella pharmacogenetictestinginacuteandchronicpainapreliminarystudy
AT lauravolonte pharmacogenetictestinginacuteandchronicpainapreliminarystudy
AT nicolapoloni pharmacogenetictestinginacuteandchronicpainapreliminarystudy
AT antonellocaserta pharmacogenetictestinginacuteandchronicpainapreliminarystudy
AT martaielmini pharmacogenetictestinginacuteandchronicpainapreliminarystudy
AT ivanocaselli pharmacogenetictestinginacuteandchronicpainapreliminarystudy
AT giulialucca pharmacogenetictestinginacuteandchronicpainapreliminarystudy
AT camillacallegari pharmacogenetictestinginacuteandchronicpainapreliminarystudy